Clinical significance of different types ofp53gene alteration in surgically treated prostate cancer-Reference-Cited by-同舟云学术

Clinical significance of different types ofp53gene alteration in surgically treated prostate cancer

Published:2014-04-26 Issue:6 Volume:135 Page:1369-1380
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kluth Martina¹,Harasimowicz Silvia¹,Burkhardt Lia¹,Grupp Katharina¹,Krohn Antje¹,Prien Kristina¹,Gjoni Jovisa¹,Haß Thomas¹,Galal Rami¹,Graefen Markus²,Haese Alexander²,Simon Ronald¹,Hühne-Simon Julia¹,Koop Christina¹,Korbel Jan³,Weischenfeld Joachim³,Huland Hartwig²,Sauter Guido⁴,Quaas Alexander¹,Wilczak Waldemar¹,Tsourlakis Maria-Christina¹,Minner Sarah¹,Schlomm Thorsten²⁴

Affiliation:

1. Institute of Pathology, University Medical Center Hamburg-Eppendorf; Hamburg Germany

2. Martini-Clinic Prostate Cancer Center; University Medical Center Hamburg-Eppendorf; Hamburg Germany

3. Genome Biology Unit; European Molecular Biology Laboratory (EMBL); Heidelberg Germany

4. Department of Urology; University Medical Center Hamburg-Eppendorf; Hamburg Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer;Mao;Am J Cancer Res,2011

2. Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis;Hanel;Cell Death Differ,2013

3. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma;Navone;J Natl Cancer Inst,1993

4. The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis;Leroy;Nucleic Acids Res,2013

5. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer;Barbieri;Nat Genet,2012

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Biomolecular Condensation and Protein Aggregation against Cancer;Chemical Reviews;2023-06-28

2. A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients;British Journal of Cancer;2023-04-10

3. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate;Theranostics;2023

4. Prostate cancer treatment – China's perspective;Cancer Letters;2022-12

5. p53 TAD2 Domain (38–61) Forms Amyloid-like Aggregates in Isolation;ACS Chemical Neuroscience;2022-07-20